Jun 11, 2015 7:00am EDT NeoGenomics Launches Twelve NeoLAB™ "Liquid Biopsy" Tests for Hematologic Diseases
Apr 28, 2015 7:00am EDT NeoGenomics Reports 27% Revenue Growth Driven by Strong Volume Gains and PathLogic Acquisition
Feb 24, 2015 7:00am EST NeoGenomics Reports Record Revenue of $25.0 Million, Adjusted EBITDA of $2.8 MM and Net Income of $0.02 per Share for the Fourth Quarter 2014
